A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia

Study Identifier
199201-010
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Results Available

Statistical Analysis Plan
Available Language(s): English
Protocol
Available Language(s): English

Study Details

Medical Condition
  • Eye Care - Other
  • Study Drug
  • AGN-199201 ophthalmic solution
  • AGN-190584 ophthalmic solution
  • AGN-199201 Vehicle
  • AGN-190584 Vehicle
  • Phase
    Phase 2
    Sex
    Female & Male
    Age
    40 - 55 Years

    Protocol Summary

    This is a safety, efficacy and pharmacokinetics study of the fixed combination of AGN-199201 and AGN-190584 in participants with presbyopia (inability to focus on items close-up).

    Study Locations

    Location
    Status
    Location
    Retina Institute of California Medical Group
    Arcadia, California, United States, 91007
    Status
    Not applicable
    Location
    Sall Research Medical Center
    Artesia, California, United States, 90701
    Status
    Not applicable
    Location
    WCCT Global, LLC
    Cypress, California, United States, 90630
    Status
    Not applicable
    Location
    Specialty Eye Care Medical Center
    Glendale, California, United States, 91203
    Status
    Not applicable
    Location
    Lugene Eye Institute
    Glendale, California, United States, 91204
    Status
    Not applicable
    Location
    The Eye Research Foundation
    Newport Beach, California, United States, 92663
    Status
    Not applicable
    Showing {first} - {last} of {total} Results